Viewing Study NCT01984606


Ignite Creation Date: 2025-12-26 @ 4:00 PM
Ignite Modification Date: 2026-03-11 @ 12:54 PM
Study NCT ID: NCT01984606
Status: WITHDRAWN
Last Update Posted: 2014-10-27
First Post: 2013-11-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module